Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Sakurai, Keitaa; * | Kaneda, Daitab | Morimoto, Satoruc | Uchida, Yutod | Inui, Shoheie | Kimura, Yasuyukif | Kato, Takashia | Ito, Kengoa | Hashizume, Yoshiob
Affiliations: [a] Department of Radiology, National Center for Geriatrics and Gerontology, Aichi, Japan | [b] Choju Medical Institute, Fukushimura Hospital, Aichi, Japan | [c] Department of Physiology, School of Medicine, Keio University, Tokyo, Japan | [d] Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan | [e] Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan | [f] Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology, Aichi, Japan
Correspondence: [*] Correspondence to: Keita Sakurai, Department of Radiology, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu, Japan. Tel.: +81 52 46 2311; E-mail: [email protected]; ORCID ID: 0000-0002-8849-7335
Abstract: Background:Due to confusing clinicoradiological features such as amnestic symptoms and hippocampal atrophy in frontotemporal lobar degeneration (FTLD), antemortem differentiation between FTLD and Alzheimer’s disease (AD) can be challenging. Although asymmetric atrophy of the cerebral peduncle is regarded as a representative imaging finding in some disorders of the FTLD spectrum, the utility of this finding has not been sufficiently evaluated for differentiating between FTLD and AD. Objective:This study aimed to explore the diagnostic performance of asymmetric cerebral peduncle atrophy on axial magnetic resonance imaging as a simple radiological discriminator between FTLD and AD. Methods:Seventeen patients with pathologically confirmed FTLD, including six with progressive supranuclear palsy, three with corticobasal degeneration, eight with TAR DNA-binding protein 43 (FTLD-TDP), and 11 with pathologically confirmed AD, were investigated. Quantitative indices representing the difference between the volumes of the bilateral cerebral peduncles (i.e., cerebral peduncular asymmetry index [CPAI]), the voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD) Z-score representing the degree of hippocampal atrophy, and semiquantitative visual analysis to evaluate the asymmetry of the cerebral peduncle (visual assessment of cerebral peduncular asymmetry: VACPA) were compared between the two groups. Results:Contrary to the VSRAD Z-score, the CPAI and VACPA scores demonstrated higher diagnostic performance in differentiating patients with FTLD from those with AD (areas under the receiver operating characteristic curve of 0.88, 082, and 0.60, respectively). Conclusions:Quantitative and visual analytical techniques can differentiate between FTLD and AD. These simple methods may be useful in daily clinical practice.
Keywords: Alzheimer’s disease, asymmetric atrophy, cerebral peduncle, corticobasal degeneration, frontotemporal lobar degeneration, magnetic resonance imaging, progressive supranuclear palsy, TDP-43 proteinopathy
DOI: 10.3233/JAD-230441
Journal: Journal of Alzheimer's Disease, vol. 95, no. 4, pp. 1657-1665, 2023
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]